Trial Profile
A phase II trial of exendin-9 in patients with bariatric surgery induced-hyperinsulinemic hypoglycemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Avexitide (Primary)
- Indications Hypoglycaemia
- Focus Therapeutic Use
- 02 Dec 2015 Results published in the Eiger Biopharmaceuticals website.
- 02 Dec 2015 New trial record